Most read article(s)

Article
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 AntibodiesAn Observational Study
Kévin Bigaut, Laurent Kremer, Thibaut Fabacher, et al.

July 28, 2021
Article
Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis
Philipp Schwenkenbecher, Thomas Skripuletz, Peter Lange, et al.

August 24, 2021
Article
Nodular Pachymeningitis Associated With Relapsing Polychondritis and Crohn Disease Responsive to Adalimumab and Prednisone
Spencer K. Hutto, Mary D. Maher, Eli M. Miloslavsky, et al.

June 02, 2021
Article
NeurosarcoidosisLongitudinal experience in a single-center, academic healthcare system
Jennifer Lord, M. Mateo Paz Soldan, Jonathan Galli, et al.

May 13, 2020
Article
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
Luca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.

August 09, 2021
Views & Reviews
Remyelination TrialsAre We Expecting the Unexpected?
Alexandr Klistorner, Michael Barnett

August 10, 2021
Article
Pilot study of a ketogenic diet in relapsing-remitting MS
J. Nicholas Brenton, Brenda Banwell, A.G. Christina Bergqvist, et al.

April 12, 2019
Editorial
Diagnosing MRI-negative autoimmune diseases
Carsten Finke

April 02, 2018
Article
Monitoring B-cell repopulation after depletion therapy in neurologic patients
Erik Ellwardt, Lea Ellwardt, Stefan Bittner, et al.

April 25, 2018
Article
Antiplexin D1 Antibodies Relate to Small Fiber Neuropathy and Induce Neuropathic Pain in Animals
Takayuki Fujii, Eun-Jae Lee, Yukino Miyachi, et al.

June 07, 2021

Pages